Headlines Covid-19 Specialties Trending Feeds Videos

OncLive® ASCO GI 2021 On Location

posted 1 day

Mashup Score: 3

studio.mjhassoc.com - OncLive® will be LIVE with OncLive® News Network: On Location at the virtual 2021 ASCO GI. Each day, we will broadcast a series of...

Pembrolizumab/Capecitabine/Bevacizumab Demonstrates Encouraging Tolerability MSS mCRC

posted 2 days

Mashup Score: 3

OncLive - January 15, 2021 – The combination use of pembrolizumab with capecitabine and bevacizumab was suggested to be tolerable in patients with microsatellite stable metastatic...

Nivolumab Improves Quality of Life in Patients with Esophageal/Gastroesophageal Cancer

posted 2 days

Mashup Score: 2

OncLive - January 15, 2021 – Patients with esophageal/gastroesophageal cancer treated with nivolumab had improved esophageal-specific and general quality of life, although trends were similar in...

Pembrolizumab Triplet Appears Effective in HER2+ Advanced Gastric, GEJ Cancer Regardless of PD-L1 Status

posted 2 days

Mashup Score: 2

OncLive - January 15, 2021 – Pembrolizumab with trastuzumab and the combination of cisplatin and capecitabine appeared effective in treating HER2-positive advanced gastric and gastroesophageal junction...

Adjuvant S-1/Docetaxel Combo Shows Survival Improvement in Stage III Gastric Cancer

posted 1 day

Mashup Score: 2

OncLive - January 15, 2021 – Combination treatment with adjuvant S-1 and docetaxel led to an estimated 29% reduction in the risk of relapse compared with...

AI-Based Tool May Help Patients Find GI Cancer Clinical Trials

posted 2 days

Mashup Score: 2

OncLive - A novel artificial intelligence-based search tool made it easier for patients to find and understand cancer clinical trials, while also offering more clarity on...

Mean Daily Step Count While Receiving SM-88 Correlated With Patient-Reported QoL in Metastatic Pancreatic Cancer

posted 14 hours

Mashup Score: 2

OncLive - January 16, 2021 – Mean daily step count during the first 2 weeks of treatment with SM-88 was found to correlate with overall self-reported...

Camrelizumab/Apatinib Shows Promising Activity in Second-Line Esophageal Squamous Cell Carcinoma

posted 2 days

Mashup Score: 1

OncLive - January 15, 2021 – A novel combination comprised of camrelizumab and apatinib was found to have promising clinical efficacy with an acceptable safety profile...

Single-Agent Lenvatinib Shows Real-World Efficacy in Frontline HCC

posted 13 hours

Mashup Score: 1

OncLive - January 16, 2021 – Lenvatinib monotherapy was found to be effective in patients with unresectable hepatocellular carcinoma in the United...

Fleshing Out HER2-Directed Therapies in GI Malignancies

posted 2 days

Mashup Score: 1

OncLive - The field of HER2-positive gastrointestinal malignancies witnessed a surge of data in 2020 regarding investigational agents, such as the antibody-drug conjugate fam-trastuzumab deruxtecan-nxki, that...